References
- World Health Organization. Rabies vaccines: WHO position paper, Weekly Epidemiological Record, No. 32, 2010, 85: 309-20.
- Sudarshan MK, Madhusudana SN, Mahendra BJ, Rao NS, Ashwath Narayana DH, Abdul Rahman S, et al. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis 2007; 11:29 - 35; http://dx.doi.org/10.1016/j.ijid.2005.10.007; PMID: 16678463
- National Institute of Communicable Diseases, Ministry of Health & Family welfare. National guidelines for rabies prophylaxis and intra-dermal administration of cell culture rabies vaccines. New Delhi, India. 2007.
- World Health Organization. WHO expert consultation on rabies. TRS 931. WHO Geneva 2005.
- Suwansrinon K, Wilde H, Benjavongkulchai M, Banjongkasaena U, Lertjarutorn S, Boonchang S, et al. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. Vaccine 2006; 24:3878 - 80; http://dx.doi.org/10.1016/j.vaccine.2006.02.027; PMID: 16530893
- Gherardin AW, Scrimgeour DJ, Lau SC, Phillips MA, Kass RB. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine. J Travel Med 2001; 8:122 - 6; http://dx.doi.org/10.2310/7060.2001.24445; PMID: 11468113
- Sudarshan MK, Ravish HS, Ashwath Narayana DH. Time interval for booster vaccination following re-exposure to rabies in previously vaccinated subjects. Asian Biomedicine 2011; 5:589 - 93
- World Health Organization. Human and dog rabies prevention and control, Report of the WHO/Bill & Melinda Gates foundation consultation, Annecy, France, 2009.
- Lang J, Duong GH, Nguyen VG, Le TT, Nguyen CV, Kesmedjian V, et al. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants. Lancet 1997; 349:1663 - 5; http://dx.doi.org/10.1016/S0140-6736(96)10085-4; PMID: 9186385
- Shanbag P, Shah N, Kulkarni M, Juvekar M, Madhusudana SN, Vakil HB, et al. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV). Hum Vaccin 2008; 4:365 - 9; http://dx.doi.org/10.4161/hv.4.5.5987; PMID: 18398307
- Kamoltham T, Thinyounyong W, Phongchamnaphai P, Phraisuwan P, Khawplod P, Banzhoff A, et al. Pre-exposure rabies vaccination of children in Thailand using Purified Chick Embryo Cell Rabies Vaccine intra dermally is immunogenic and safe. J Pedod 2007; 151:173 - 7; http://dx.doi.org/10.1016/j.jpeds.2007.02.044
- A clinical evaluation of safety and immunogenicity of purified chick embryo cell rabies vaccine (Vaxirab N) administered intradermally as pre exposure prophylaxis in healthy volunteers. 2010, India.
- A clinical evaluation of safety and immunogenicity of purified chick embryo cell rabies vaccine (Vaxirab N) administered intramuscularly as post exposure prophylaxis in animal bite cases. 2011, India.
- Current strategies for human rabies pre and post-exposure prophylaxis 2010, Available at: www.who.int/rabies/human/WHO_strategy_prepost_exposure/en/html accessed on: 12.01.2013.